Малезија - Енглески - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zontron pharmaceuticals sdn. bhd. - calcium pantothenate; cyanocobalamin; pyridoxine hcl/vitamin b6; riboflavine; thiamine mononitrate; nicotinamide -

Малезија - Енглески - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

kck pharmaceutical industries sdn. bhd. - pyridoxine hcl/vitamin b6; thiamine hydrochloride/vit b1; cyanocobalamin -

Малезија - Енглески - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

healol pharmaceuticals sdn. bhd. - iron(iii) hydroxide polymaltose complex; folic acid; ascorbic acid -

Израел - Енглески - Ministry of Health

remedix care ltd - ascorbic acid; biotin; cocarboxylase tetrahydrate; colecalciferol; cyanocobalamin; dexpanthenol; folic acid; nicotinamide; pyridoxine (vit b6) hydrochloride; retinol palmitate; riboflavine; tocopherol - powder for solution for injection - retinol palmitate 3500 iu/vial; colecalciferol 220 iu/vial; tocopherol 10.2 mg/vial; ascorbic acid 125 mg/vial; riboflavine 5.67 mg/vial; pyridoxine (vit b6) hydrochloride 5.5 mg/vial; cyanocobalamin 0.006 mg/vial; folic acid 0.414 mg/vial; dexpanthenol 16.15 mg/vial; biotin 0.069 mg/vial; nicotinamide 46 mg/vial; cocarboxylase tetrahydrate 5.8 mg/vial - combinations - vitamin supplementation in patients receiving parenteral nutrition. only for adults and children over 11 years of age.

Арменија - Енглески - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

interchemie werken de adelaar eesti as - oxytetracycline (oxytetracycline hydrochloride) - spray - 25mg/ml

Арменија - Енглески - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

interchemie werken 'de adelaar' b.v. - doxycycline (doxycycline hyclate) - powder oral - 500mg/g

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

epic pharma, llc - ethambutol hydrochloride (unii: qe4vw5fo07) (ethambutol - unii:8g167061qz) - ethambutol hydrochloride tablets, usp are indicated for the treatment of pulmonary tuberculosis. it should not be used as the sole antituberculous drug, but should be used in conjunction with at least one other antituberculous drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety, and appropriate in vitro susceptibility studies. in patients who have not received previous antituberculous therapy, i.e., initial treatment, the most frequently used regimens have been the following: ethambutol hydrochloride, usp plus isoniazid ethambutol hydrochloride, usp plus isoniazid plus streptomycin in patients who have received previous antituberculous therapy, mycobacterial resistance to other drugs used in initial therapy is frequent. consequently, in such retreatment patients, ethambutol hydrochloride should be combined with at least one of the second line drugs not previously administered to the patient and to which bacterial susceptibility has been indicated by appropriate in vitro studies. antituberculous drugs used with ethambutol hydrochloride have included cycloserine, ethionamide, pyrazinamide, viomycin and other drugs. isoniazid, aminosalicylic acid, and streptomycin have also been used in multiple drug regimens. alternating drug regimens have also been utilized. ethambutol hydrochloride is contraindicated in patients who are known to be hypersensitive to this drug. it is also contraindicated in patients with known optic neuritis unless clinical judgment determines that it may be used. ethambutol hydrochloride is contraindicated in patients who are unable to appreciate and report visual side effects or changes in vision (e.g., young children, unconscious patients).

Арменија - Енглески - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

interchemie werken "de adelaar" eesti as - oxytetracycline (oxytetracycline dihydrate) - solution for injection - 200mg/ml

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

remedyrepack inc. - ethambutol hydrochloride (unii: qe4vw5fo07) (ethambutol - unii:8g167061qz) - ethambutol hydrochloride is indicated for the treatment of pulmonary tuberculosis. it should not be used as the sole antituberculous drug, but should be used in conjunction with at least one other antituberculous drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety and appropriate in-vitro susceptibility studies. in patients who have not received previous antituberculous therapy, i.e., initial treatment, the most frequently used regimens have been the following: - ethambutol plus isoniazid - ethambutol plus isoniazid plus streptomycin. in patients who have received previous antituberculous therapy, mycobacterial resistance to other drugs used in initial therapy is frequent. consequently, in such retreatment patients, ethambutol should be combined with at least one of the second line drugs not previously administered to the patient and to which bacterial susceptibility has been indicated by appropriate in-vitro studies. antituberculous drugs used with ethambutol have included cycloserine, ethionamide, pyrazinamide, viomycin and other drugs. isoniazid, aminosalicylic acid, and streptomycin have also been used in multiple drug regimens. alternating drug regimens have also been utilized. ethambutol hydrochloride is contraindicated in patients who are known to be hypersensitive to this drug. it is also contraindicated in patients with known optic neuritis unless clinical judgement determines that it may be used. ethambutol hydrochloride is contraindicated in patients who are unable to appreciate and report visual side effects or changes in vision (e.g., young children, unconscious patients).

Јужноафричка Република - Енглески - South African Health Products Regulatory Authority (SAHPRA)

pharma dynamics (pty) ltd - tablet - 75,0 mg - each tablet contains isoniazid 50,0 mgrifampicin 75,0 mg